Cross-fund · 6 holders
ALNY
ALNYLAM PHARMACEUTICALS INC
CUSIP 02043Q107
6
Tracked holders
$9.08B
Aggregate value
24,716,034
Shares
6
Active funds
Funds holding ALNY
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $5.39B | 0.08% | -11,520 | -0.1% |
| BlackRock | Institutional | Q1 2026 | $3.46B | 0.06% | +44,034 | +0.4% |
| Millennium | Multi-Strategy | Q1 2026 | $163.1M | 0.07% | +406,657 | +470.5% |
| Citadel | Multi-Strategy | Q1 2026 | $36.8M | 0.01% | -75,044 | -40.3% |
| BridgewaterFEAT | Macro | Q1 2026 | $35.3M | 0.16% | +20,975 | +24.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $2.1M | — | -4,800 | -43.2% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.